For
the three months ended March 31, 2026 and 2025, the calculations of basic and diluted loss per share are the same because potential dilutive
securities would have had an antidilutive effect. The potentially dilutive securities consisted of the following:
Schedule of Potentially Dilutive Securities
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Warrants | |
| 2,963,215 | | |
| 91,549 | |
| Options | |
| 25,191 | | |
| 54,034 | |
| Common stock equivalent of Series A Convertible Preferred stock | |
| 125 | | |
| 125 | |
| Total | |
| 2,988,531 | | |
| 145,708 | |
| Anti-dilutive Securities | |
| 2,988,531 | | |
| 145,708 | |
|